Marburgvirus Infection Market
Marburgvirus Infection Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Marburgvirus Infection Market Size and Growth
The Marburgvirus infection market is rapidly evolving due to increasing awareness and emerging therapeutic developments. The global market size is projected to reach approximately $500 million by 2025, driven by heightened surveillance, research funding, and vaccine initiatives. Continued efforts in outbreak management will further shape market dynamics and growth opportunities.
Companies Covered
(Covid 19 Impact Covered)
◍ Arno Therapeutics Inc
◍ BioCryst Pharmaceuticals Inc
◍ Eisai Co Ltd
◍ Emergent BioSolutions Inc
◍ Fab'entech SA
◍ Integrated BioTherapeutics Inc
◍ Johnson & Johnson
◍ NanoViricides Inc
◍ Profectus BioSciences Inc
◍ Rodos BioTarget GmbH
◍ Sarepta Therapeutics Inc
◍ Theravectys SA
The Marburgvirus infection market is competitive, with companies like Arno Therapeutics, BioCryst Pharmaceuticals, and Johnson & Johnson developing innovative therapies and vaccines. These firms contribute to market growth through R&D, collaborations, and emerging technologies. Sales figures include:
- Johnson & Johnson: $93.8 billion (2022)
- BioCryst Pharmaceuticals: $65 million (2022)
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Others
By Product
◍ Eritoran Tetrasodium
AR-12
ARD-5
AVI-7288
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
